Our study is the first to delineate chronological changes of hepatocyte transporters and nuclear receptors in human obstructive cholestasis. The gene expression pattern was quite different between ...

The HPA axis dysfunctions were extensively studied in neuroendocrine disorders such as depression and chronic fatigue syndrome but less so in hepatic cholestasis, cirrhosis or other liver diseases.

Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related death globally and liver transplantation (LT) can serve as the best curative treatment option. However, HCC recurrence ...

7 Center for Stem Cell and Regenerative Medicine, Zhejiang University School of Medicine, Hangzhou, China Objective Hepatocellular carcinoma (HCC ... while other lesions looked yellow with cholestasis ...

Recent studies have challenged the assumption that these agents are equally effective at preventing hepatocellular ... patterns would be warranted if these findings were shown to be consistent across ...

In a blog post by Player First Games, the team stated that, with the release of Season 5 on February 4th, MultiVersus will stop receiving updates and support come its end date of May 30th.

MultiVersus will go offline on May 30, 2025. The free-to-play fighting game has failed to capture a strong player base, costing Warner Bros. upwards of $100 million by late 2024. MultiVersus will ...

Background: There is no clear consensus on the better therapy [radiofrequency ablation (RFA) versus hepatic resection (HR)] for small hepatocellular carcinoma (HCC) eligible for surgical treatments.

Acute hepatic decompensation has been estimated to occur in 20%, [120] while liver failure occurs in a median of 7.5% after TACE but with a wide reported range (0-48.6%). Maria Pleguezuelo ...

Efficacy and safety of endoscopic retrograde cholangiopancreatography (ERCP) vs percutaneous transhepatic biliary drainage (PTBD) for cholangiocarcinoma biliary obstruction: An updated systematic ...

Zanidatamab dose optimization in patients with HER2-positive biliary tract cancer (BTC). Real-world survival differences in advanced biliary tract cancer patients with ctDNA detected IDH1 mutations ...